Shares of Fresenius Medical Care AG & Co. (Pref) (ETR:FME) have been assigned a consensus recommendation of “Hold” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is €89.12 ($104.84).

Several equities research analysts have recently weighed in on FME shares. Morgan Stanley set a €90.00 ($105.88) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Friday, September 15th. Nord/LB set a €93.00 ($109.41) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Thursday. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Friday, September 29th. J P Morgan Chase & Co set a €106.40 ($125.18) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Wednesday, August 2nd. Finally, Berenberg Bank set a €95.60 ($112.47) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Tuesday, September 5th.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.watchlistnews.com/fresenius-medical-care-ag-co-pref-fme-given-average-rating-of-hold-by-analysts/1676235.html.

Shares of Fresenius Medical Care AG & Co. (FME) traded up €0.18 ($0.21) on Friday, hitting €83.20 ($97.88). The stock had a trading volume of 656,887 shares.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with Analyst Ratings Network's FREE daily email newsletter.